12:00 AM
 | 
Dec 07, 2015
 |  BC Week In Review  |  Company News  |  Deals

Amdipharm Mercury, Concordia Healthcare deal

Concordia completed its acquisition of fellow generic and pharmaceutical company Amdipharm from private equity firm Cinven for $3.1 billion, including $1.4 billion in debt. The acquisition consists of L800 million ($1.2 billion) in cash, $47.5...

Read the full 153 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >